I know it's an unusual one but I keep looking at charts like invion. they were 0.002 in August 2017 then whammo. new product licenced and a 2400% gain six months later at its peak. it has now settled but is still 1000% up from its price ore new acquisition.
iil/ atx was up 300% on their new acquisition. it has settled back now as it was a very early stage product but it will run again when the time is right.
you see it happen time and again in biotech and probabilistically I like the chances for ftt. the past is the past. but from where we are right now in 2019 if I want to make money (which is why I am here) ftt has good odds to me. obviously it's not an all eggs in one basket deal, and should never be, but it's in my portfolio with the aim of getting a return.
the only reason my sentiment is currently "none" is because of the threat of these new contenders. otherwise it would be a screaming buy...
FTT Price at posting:
0.4¢ Sentiment: None Disclosure: Held
